K.U.LEUVEN R AND D;UCB BIOPHARMA SPRL;KATHOLIEKE UNIVERSITEIT LEUVEN, K.U.LEUVEN R AND D;KATHOLIEKE UNIVERSITEIT LEUVEN
发明人:
FORD, DANIEL JAMES,FRANKLIN, RICHARD JEREMY,GHAWALKAR, ANANT RAMRAO,HORSLEY, HELEN TRACEY,HUANG, QIUYA,REUBERSON, JAMES THOMAS,VANDERHOYDONCK, BART
申请号：
PH12015501222
公开号：
PH12015501222A1
申请日:
2015.06.01
申请国别(地区):
PH
年份:
2015
代理人:
摘要：
A series of pyrazolo[3,4-d]pyrimidine derivatives that are substituted at the 4- position by a diaza monocyclic, bridged bicyclic or spirocyclic moiety, are beneficial in the treatment and/or prevention of various human ailments, including inflammatory, autoimmune and oncological disorders； viral diseasesand malaria； and organ and cell transplant rejection.
